BIT Biotech Opportunities I-II Fonds
95,30
EUR
+1,87
EUR
+2,00
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| BridgeBio Pharma Inc | US10806X1028 | 7,25% |
| BioNTech SE ADR | US09075V1026 | 6,94% |
| ATAI Life Sciences NV | NL0015000DX5 | 6,15% |
| Revolution Medicines Inc Ordinary Shares | US76155X1000 | 5,79% |
| Scholar Rock Holding Corp | US80706P1030 | 5,50% |
| Viridian Therapeutics Inc | US92790C1045 | 5,03% |
| Enliven Therapeutics Inc | US29337E1029 | 5,00% |
| Day One Biopharmaceuticals Inc | US23954D1090 | 4,93% |
| Agios Pharmaceuticals Inc | US00847X1046 | 4,63% |
| Akero Therapeutics Inc | US00973Y1082 | 4,57% |
| Sonstige | 44,20% |